Sterile Intraocular Inflammation Associated With Faricimab

Uveitis

Intraocular Inflammation (IOI) Associated with Faricimab Therapy: One-year Real World Outcomes

Retina

Montesel A, Sen S, Preston E, Patel PJ, Huemer J, Hamilton RD, Nicholson L, Papasavvas I, Tucker WR, Yeung I

doi: 10.1097/IAE.0000000000004394

Macular DiseasesFurther Publications

Severe intraocular inflammation after intravitreal injection of faricimab: a single-site case series of six patients

Am J Ophthalmol

Ghezala IB, Gabrielle PH, Sibert M, Steinberg LA, Dautriche A, Arnould L, Creuzot-Garcher C

doi: 10.1016/j.ajo.2024.08.008

Glaucoma and Ocular Pressure

Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure Change

Am J Ophthalmol

Hallaj S, Halfpenny W, Chuter BG, Weinreb RN, Baxter SL, Cui QN

doi: 10.1016/j.ajo.2024.08.030

Uveitis

Incidence of intraocular inflammation and its risk factors in patients treated with brolucizumab: a nationwide cohort study

Sci Rep

Park HS, Lee SW, Park H, Lee NK, Kim YJ, Lee CS, Byeon SH, Kim SS

doi: 10.1038/s41598-024-73782-1

Glaucoma and Ocular PressureRetinal Diseases

Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study

Br J Ophthalmol

Paris A, Volpe G, Perruchoud-Ader K, Casanova A, Menghini M, Grimaldi G

doi: 10.1136/bjo-2024-326053

Macular Diseases

Risk of intraocular pressure elevation associated with triamcinolone acetonide administration via different routes in macular edema: a systematic review and network meta-analysis of randomized controlled trials

BMC Ophthalmol

Liu K, Yi J, Xu J, Zhong L, Su N

doi: 10.1186/s12886-025-03979-z

Further Publications

Drugs Associated with Floppy Iris Syndrome: A Real-World Population-Based Study: Drugs Associated with Floppy Iris Syndrome

Am J Ophthalmol

Lakhani M, Kwan ATH, Mihalache A, Popovic MM, Hurley B, Muni RH

doi: 10.1016/j.ajo.2025.03.023

Glaucoma and Ocular Pressure

Relationship between intraocular pressure and pulmonary function

Sci Rep

Terauchi R, Fukai K, Fujimoto S, Ito K, Kato T, Kato K, Tatemichi M, Araya J, Kabata Y, Nakano T

doi: 10.1038/s41598-025-05731-5

Macular Diseases

One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration

Ophthalmol Ther

Cancian G, Paris A, Agliati L, Rizzato A, Clerici M, Volpe G, Menghini M, Grimaldi G

doi: 10.1007/s40123-024-01036-4

Related content

Intraocular Inflammation (IOI) Associated with Faricimab Therapy: One-year Real World Outcomes

Severe intraocular inflammation after intravitreal injection of faricimab: a single-site case series of six patients

Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure Change

Incidence of intraocular inflammation and its risk factors in patients treated with brolucizumab: a nationwide cohort study

Short-term intraocular pressure changes after intravitreal aflibercept 2 mg, aflibercept 8 mg and faricimab: a prospective, comparative study

Risk of intraocular pressure elevation associated with triamcinolone acetonide administration via different routes in macular edema: a systematic review and network meta-analysis of randomized controlled trials

Drugs Associated with Floppy Iris Syndrome: A Real-World Population-Based Study: Drugs Associated with Floppy Iris Syndrome

Relationship between intraocular pressure and pulmonary function

One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration